Setanta Nutrition Science will disrupt the nutraceutical, food supplement and diabetic food industries by creating natural, plant-based, whole-food products to prevent and treat diabetes, based in science, proven by research. The business operates in the $272.35 billion nutraceutical category.

Diabetes is an incurable disease with serious individual and societal consequences.
~800 million people are affected by (pre)diabetes globally, cost of $727 billion/year.

Conor Kerley, doctor of nutrition, leading dietitian and award winning researcher has formulated an all natural, plant-based food supplement based on his own scientific research, providing a natural and convenient way to improve blood sugar control.

The proprietary blend includes a branded, trademarked ingredient and is composed of some of the healthiest and most powerful natural ingredients in specific quantities,

Our route to market will include face to face but the vision for the business is to scale through nationa...
Setanta Nutrition Science will disrupt the nutraceutical, food supplement and diabetic food industries by creating natural, plant-based, whole-food products to prevent and treat diabetes, based in science, proven by research. The business operates in the $272.35 billion nutraceutical category.

Diabetes is an incurable disease with serious individual and societal consequences.
~800 million people are affected by (pre)diabetes globally, cost of $727 billion/year.

Conor Kerley, doctor of nutrition, leading dietitian and award winning researcher has formulated an all natural, plant-based food supplement based on his own scientific research, providing a natural and convenient way to improve blood sugar control.

The proprietary blend includes a branded, trademarked ingredient and is composed of some of the healthiest and most powerful natural ingredients in specific quantities,

Our route to market will include face to face but the vision for the business is to scale through national and then UK, EU and global retails and particularly online sales.
Based on a superior product, with a strong brand and a large, growing customer base. -Customer segments: newly diagnosed diabetics, pre-diabetics; severe diabetics.

Our start up business is not currently generating revenue. We have produced prototypes and completed initial feasibility testing but we’re not market ready yet.
Progress includes near final formulation, sourced supplier, manufacturer and distributor, preliminary market research and early stage discussions with retail pharmacies and brand ambassadors. In addition, an expert, foundation team has been formed.

Preliminary market research with potential customers as well as stakeholders completed and positive. Entered early stage discussions with retail pharmacies and brand ambassadors.

Preliminary market research with potential customers as well as stakeholders completed and positive. Entered early stage discussions with retail pharmacies and brand ambassadors.

The vision for the business is to scale through global online and retails sales based on a superior product, with a strong brand and a large, growing customer base.

Therefore, we have high potential to grow, quickly, due to:
• Large market opportunity,
• Superior product with multiple USPs,
• Healthy financial projections,
• Ambitious, expert, experienced and diverse team,
• Plan in place to make it happen.
More information

Investors

EIT Food Seedbed 2020
Admin
EIT Food Seedbed 2020 The funds, network and skills to validate your agrifood business model

Advisors

Pat Kerley
Admin
Ian Sutton
Admin
Ian Sutton

Employees

Conor Kerley
Admin
Conor Kerley CEO I’m organised, energetic & ambitious with natural passion for helping others. I’m a proven enthusiastic self-starter, team player & leader.